Economic Evaluation of Cinacalcet in the Treatment of Secondary Hyperparathyroidism in Italy.
- Published in:
- PharmacoEconomics, 2010, v. 28, n. 11, p. 1041, doi. 10.2165/11538600-000000000-00000
- By:
- Publication type:
- Article
Works matching AU Chiroli, Silvia
Results: 11
1
2
Number-Needed-To-Treat (NNT) and Cost of Responses Achieved in Tyrosine Kinase Inhibitor (TKI) Treatment of Refractory Chronic-Phase Chronic Myeloid Leukemia (CP-CML) in the United States (US).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S310, doi. 10.1016/j.clml.2017.07.109
- By:
- Publication type:
- Article
3
Ponatinib versus Bosutinib in 3rd-Line Chronic Phase - Chronic Myeloid Leukemia (CP-CML): Indirect Comparison of Efficacy Using Iterative Proportional Fitting.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2016, v. 16, p. S58, doi. 10.1016/j.clml.2016.07.085
- By:
- Publication type:
- Article
4
Benefits and risks of ponatinib versus bosutinib following treatment failure of two prior tyrosine kinase inhibitors in patients with chronic phase chronic myeloid leukemia: a matching-adjusted indirect comparison.
- Published in:
- 2019
- By:
- Publication type:
- journal article
5
Is there an association between elevated or low serum levels of phosphorus, parathyroid hormone, and calcium and mortality in patients with end stage renal disease? A meta-analysis.
- Published in:
- BMC Nephrology, 2013, v. 14, n. 1, p. 1, doi. 10.1186/1471-2369-14-88
- By:
- Publication type:
- Article
6
Is there an association between elevated or low serum levels of phosphorus, parathyroid hormone, and calcium and mortality in patients with end stage renal disease? A meta-analysis.
- Published in:
- 2013
- By:
- Publication type:
- journal article
7
Impact of mineral and bone disorder on healthcare resource use and associated costs in the European Fresenius medical care dialysis population: a retrospective cohort study.
- Published in:
- BMC Nephrology, 2012, v. 13, n. 1, p. 140, doi. 10.1186/1471-2369-13-140
- By:
- Publication type:
- Article
8
Clinical efficacy comparison of avapritinib with other tyrosine kinase inhibitors in gastrointestinal stromal tumors with PDGFRA D842V mutation: a retrospective analysis of clinical trial and real-world data.
- Published in:
- 2021
- By:
- Publication type:
- journal article
9
Cost Effectiveness of the Third-Generation Tyrosine Kinase Inhibitor (TKI) Ponatinib, vs. Second-Generation TKIs or Stem Cell Transplant, as Third-Line Treatment for Chronic-Phase Chronic Myeloid Leukemia.
- Published in:
- Applied Health Economics & Health Policy, 2019, v. 17, n. 4, p. 555, doi. 10.1007/s40258-019-00489-0
- By:
- Publication type:
- Article
10
A Cost-Utility Analysis of Cinacalcet in Secondary Hyperparathyroidism in Five European Countries.
- Published in:
- Applied Health Economics & Health Policy, 2012, v. 10, n. 2, p. 127, doi. 10.2165/11597980-000000000-00000
- By:
- Publication type:
- Article
11
Efgartigimod improved health-related quality of life in generalized myasthenia gravis: results from a randomized, double-blind, placebo-controlled, phase 3 study (ADAPT).
- Published in:
- Journal of Neurology, 2023, v. 270, n. 4, p. 2096, doi. 10.1007/s00415-022-11517-w
- By:
- Publication type:
- Article